Cranex Ltd Q4 FY26: Strong Quarter Masks Underlying Concerns

8 hours ago
share
Share Via
Cranex Limited, a micro-cap industrial manufacturing company specialising in EOT and Gantry Cranes, delivered a strong Q4 FY26 performance with net profit surging to ₹1.18 crores, marking a sharp 268.75% quarter-on-quarter increase and a 22.92% year-on-year gain. However, the stock has tumbled 3.58% following the results announcement, reflecting investor concerns about sustainability and broader market weakness. With a market capitalisation of just ₹50.00 crores, the company trades at ₹73.63, down 25.25% from its 52-week high of ₹98.50.
Cranex Ltd Q4 FY26: Strong Quarter Masks Underlying Concerns

Whilst the March quarter showcased impressive headline numbers driven by revenue acceleration and margin expansion, the company's longer-term trajectory reveals persistent challenges including weak return ratios, high leverage, and significant underperformance against both sector peers and broader market indices over the past year.

Net Profit (Q4 FY26)
₹1.18 Cr
▲ 268.75% QoQ
Revenue Growth (YoY)
+18.69%
Q4 FY26 vs Q4 FY25
Operating Margin
8.76%
Highest in 8 quarters
PAT Margin
5.39%
Improved from 2.88%

The March quarter results represent a significant operational turnaround from the preceding December quarter, when net profit stood at a modest ₹0.32 crores. Revenue in Q4 FY26 jumped to ₹21.91 crores, representing a remarkable 97.03% sequential increase and an 18.69% year-on-year improvement. This revenue acceleration appears to be driven by order execution timing rather than fundamental demand shifts, a pattern evident in the company's historically volatile quarterly performance.

Quarter Revenue (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change Operating Margin
Mar'26 21.91 +97.03% 1.18 +268.75% 8.76%
Dec'25 11.12 -16.83% 0.32 -51.52% 7.91%
Sep'25 13.37 +48.89% 0.66 +175.00% 7.93%
Jun'25 8.98 -51.35% 0.24 -75.00% 7.80%
Mar'25 18.46 +68.89% 0.96 +966.67% 9.21%
Dec'24 10.93 -17.38% 0.09 -87.14% 6.31%
Sep'24 13.23 0.70 7.41%

Financial Performance: Quarterly Surge Belies Annual Weakness

Whilst Q4 FY26 delivered encouraging numbers, a broader analysis reveals concerning patterns. On a full-year basis for FY25, Cranex reported net sales of ₹51.00 crores, representing a 17.70% contraction from the previous year's ₹62.00 crores. Annual net profit stood at just ₹1.00 crore in FY25, flat compared to FY24, indicating that the company's profitability remains stubbornly stagnant despite occasional quarterly spikes.

The March quarter's operating profit before depreciation, interest, and tax (PBDIT) excluding other income reached ₹1.92 crores, yielding an operating margin of 8.76%—the highest recorded in the past eight quarters. This represents a notable improvement from the 7.91% achieved in December 2025 and compares favourably to the 9.21% posted in March 2025. However, the sustainability of this margin expansion remains questionable given the company's history of volatile quarterly performance.

Employee costs in Q4 FY26 stood at ₹1.76 crores, up from ₹1.60 crores in the previous quarter, representing a measured 10.00% sequential increase that was well-controlled relative to the 97.03% revenue surge. This operational leverage contributed meaningfully to the quarter's margin improvement. Interest costs declined marginally to ₹0.37 crores from ₹0.40 crores, providing modest relief despite the company's elevated debt burden.

Net Sales (Q4 FY26)
₹21.91 Cr
▲ 97.03% QoQ | ▲ 18.69% YoY
Net Profit (Q4 FY26)
₹1.18 Cr
▲ 268.75% QoQ | ▲ 22.92% YoY
Operating Margin (Excl OI)
8.76%
vs 7.91% in Dec'25
PAT Margin
5.39%
vs 2.88% in Dec'25

Operational Challenges: Weak Return Ratios and High Leverage

Despite the encouraging quarterly performance, Cranex continues to struggle with fundamental operational weaknesses that constrain its investment appeal. The company's average return on capital employed (ROCE) stands at just 7.38% over the past several years, significantly below the threshold typically expected by quality-focused investors. Similarly, the average return on equity (ROE) of 10.33% remains modest, particularly when considered against the company's elevated leverage profile.

The latest ROCE of 8.76%, whilst representing the company's highest half-yearly figure, still reflects suboptimal capital efficiency. This weakness in return ratios suggests that Cranex is not generating adequate returns relative to the capital deployed in its business, a structural concern that cannot be dismissed based on a single strong quarter.

The company's balance sheet reveals significant leverage concerns. Long-term debt stood at ₹2.21 crores as of March 2025, down substantially from ₹6.51 crores in the previous year, indicating some deleveraging progress. However, the average debt-to-EBITDA ratio of 8.68 times remains alarmingly high, signalling that the company carries excessive debt relative to its cash-generating capacity. The average net debt-to-equity ratio of 0.73 further underscores this leverage burden.

Key Concern: Capital Efficiency Remains Weak

With an average ROCE of 7.38% and average ROE of 10.33%, Cranex demonstrates below-average capital efficiency. The company's average EBIT-to-interest coverage ratio of just 1.99 times indicates limited cushion to service debt obligations, particularly concerning given the elevated debt-to-EBITDA ratio of 8.68 times. These metrics collectively point to structural profitability challenges that extend beyond quarterly volatility.

Industry Context: Underperforming the Sector

Cranex operates in the industrial manufacturing sector, specifically focusing on electric overhead travelling (EOT) cranes and gantry cranes for government and private sector industries. The company's positioning as a micro-cap player with a market capitalisation of just ₹50.00 crores places it amongst the smaller operators in this capital-intensive industry.

Over the past year, Cranex has significantly underperformed its sector. The stock delivered a negative return of 19.97% over the 12-month period ending May 29, 2026, whilst the broader industrial manufacturing sector posted a marginal decline of just 0.17%. This 19.80 percentage point underperformance reflects investor scepticism about the company's ability to sustain growth and profitability.

The company's five-year sales compound annual growth rate (CAGR) of 10.63% appears respectable on the surface, demonstrating some revenue expansion capability. However, this growth has not translated into meaningful shareholder value creation, as evidenced by the company's weak return ratios and volatile profitability profile. The five-year EBIT CAGR of 32.47% suggests improving operational efficiency over the longer term, though this metric is heavily influenced by a low base effect.

Peer Comparison: Valuation Appears Reasonable but Quality Lags

When benchmarked against industry peers, Cranex presents a mixed picture. The company trades at a price-to-earnings (P/E) ratio of 23.06 times trailing twelve-month earnings, which appears reasonable compared to the industry average P/E of 35 times. The price-to-book value (P/BV) ratio of 2.00 times also sits below the peer average, suggesting the stock is not demanding an excessive premium.

Company P/E (TTM) P/BV ROE (%) Debt/Equity
Cranex 23.06 2.00 10.33% 0.73
Envair Electrodyne 483.11 6.58 0.00% -0.77
Manugraph India NA (Loss Making) 0.79 1.37% 0.01
Ultra Wiring 15.33
Chamunda Electricals 14.74
Ahlada Engineers 24.58

However, valuation multiples tell only part of the story. Cranex's ROE of 10.33% stands out favourably compared to peers like Envair Electrodyne (0.00%) and Manugraph India (1.37%), suggesting relatively better capital efficiency within this peer group. The company's debt-to-equity ratio of 0.73 sits in the middle of the pack, indicating neither exceptional balance sheet strength nor alarming leverage when compared to immediate competitors.

The key challenge is that this entire peer group comprises micro-cap, below-average quality companies with limited institutional following. Cranex ranks second by market capitalisation amongst this cohort, but this positioning offers little comfort given the overall quality concerns across the group.

Valuation Analysis: Attractive Entry Point with Significant Risks

From a pure valuation perspective, Cranex currently trades at levels that the company's proprietary scoring system categorises as "Very Attractive." The stock's enterprise value-to-EBITDA multiple of 15.79 times and enterprise value-to-capital employed ratio of 1.58 times suggest the market is not pricing in aggressive growth expectations.

The company's PEG ratio of 3.57, whilst elevated, reflects the challenge of valuing a business with volatile earnings and modest growth visibility. At the current price of ₹73.63, the stock trades 25.25% below its 52-week high of ₹98.50 and 31.48% above its 52-week low of ₹56.00, positioning it in the middle of its recent trading range.

The valuation grade has undergone multiple changes over the past year, shifting from "Expensive" in late January 2025 to "Fair" in early March, then "Attractive" by late March, and finally "Very Attractive" by October 2025. This progression reflects the stock's price decline rather than fundamental improvement, with the current ₹73.63 level representing a significant discount to earlier valuations.

P/E Ratio (TTM)
23.06x
vs Industry 35x
P/BV Ratio
2.00x
Book Value: ₹28.24
EV/EBITDA
15.79x
Moderate multiple
Valuation Grade
Very Attractive
Since Oct'25

Shareholding Pattern: Stable Promoter Base, Minimal Institutional Interest

The shareholding structure of Cranex reveals a stable promoter base with minimal institutional participation. Promoter holding stood at 47.70% as of April 2026, representing a marginal 0.13 percentage point increase from the previous quarter's 47.57%. This modest uptick suggests stable promoter confidence, though the absolute level of promoter holding remains below the 50% threshold often viewed as providing strong alignment.

Shareholder Category Apr'26 Mar'26 Dec'25 QoQ Change
Promoter Holding 47.70% 47.57% 47.57% +0.13%
FII Holding 0.00% 0.00% 0.00%
Mutual Fund Holding 0.00% 0.00% 0.00%
Other DII Holdings 0.28% 0.34% 0.34% -0.06%
Non-Institutional 52.02% 52.09% 52.09% -0.07%

The complete absence of foreign institutional investor (FII) and mutual fund holdings underscores the stock's lack of institutional appeal. Total institutional holdings stand at a negligible 0.28%, concentrated entirely in the "Other DII" category, which itself declined by 0.06 percentage points in the latest quarter. This institutional void reflects the company's micro-cap status, limited liquidity, and below-average quality profile.

Non-institutional investors hold 52.02% of the equity, representing retail and high-net-worth individual participation. The marginal 0.07 percentage point decline in this category during the latest quarter suggests no significant change in retail investor sentiment. Importantly, promoters have not pledged any shares, eliminating one potential risk factor.

Stock Performance: Severe Underperformance Across Timeframes

The stock's price performance paints a concerning picture of sustained underperformance across most relevant timeframes. Over the past year, Cranex has declined 19.97%, significantly lagging the Sensex's 8.40% decline and generating negative alpha of 11.57 percentage points. This underperformance extends to the two-year period, with the stock down 18.19% compared to the Sensex's marginal 0.37% gain.

Period Stock Return Sensex Return Alpha
1 Week -7.51% -0.85% -6.66%
1 Month -15.95% -3.51% -12.44%
3 Months +2.28% -8.01% +10.29%
6 Months +6.05% -12.75% +18.80%
YTD +8.61% -12.26% +20.87%
1 Year -19.97% -8.40% -11.57%
2 Years -18.19% +0.37% -18.56%
3 Years +102.06% +18.98% +83.08%

However, longer-term returns present a more favourable picture. Over three years, the stock has delivered a 102.06% return, substantially outperforming the Sensex's 18.98% gain and generating positive alpha of 83.08 percentage points. The five-year return of 637.04% and ten-year return of 718.11% demonstrate exceptional wealth creation for patient, long-term investors who entered at significantly lower valuations.

The stock's recent weakness is evident in shorter timeframes. Over the past week, Cranex declined 7.51%, underperforming the Sensex by 6.66 percentage points. The one-month decline of 15.95% similarly lags the broader market's 3.51% decline. These near-term losses reflect both company-specific concerns and broader market volatility.

From a technical perspective, the stock currently trades below all key moving averages—5-day (₹77.32), 20-day (₹83.53), 50-day (₹77.56), 100-day (₹74.50), and 200-day (₹76.44)—signalling technical weakness. The overall technical trend is classified as "Mildly Bullish" as of May 22, 2026, representing a recent shift from "Mildly Bearish," though this classification appears tentative given the stock's position relative to moving averages.

"Whilst the March quarter delivered impressive headline numbers, the company's structural challenges—weak return ratios, high leverage, and persistent volatility—suggest investors should temper expectations."

Investment Thesis: Mixed Signals Across Parameters

The investment case for Cranex presents a complex mosaic of contradictory signals. The company's proprietary Mojo Score of 50 out of 100 places it firmly in "HOLD" territory, reflecting the balanced nature of bullish and bearish factors. This score represents a significant improvement from the "Strong Sell" rating of 31 assigned as recently as October 2025, primarily driven by valuation becoming more attractive as the stock price declined.

Breaking down the four key assessment parameters reveals the source of this ambiguity. Near-term drivers appear positive, with the quarterly financial trend classified as "Positive" and technicals rated "Mildly Bullish." However, quality remains "Below Average," reflecting the company's weak long-term return on capital employed and modest profitability metrics. Valuation is deemed "Attractive" at current levels, providing the primary support for the Hold rating.

Valuation
Attractive
Very Attractive grade
Quality Grade
Below Average
Weak ROCE/ROE
Financial Trend
Positive
Q4 FY26 strong
Technical Trend
Mildly Bullish
Recent shift

Key Strengths & Risk Factors

✅ Key Strengths

Strong Q4 Performance: Net profit of ₹1.18 crores represents highest quarterly profit in recent history, with 268.75% QoQ growth.
Margin Expansion: Operating margin of 8.76% in Q4 FY26 marks the best performance in eight quarters, demonstrating improved operational efficiency.
Attractive Valuation: P/E of 23.06x trades below industry average of 35x, whilst P/BV of 2.00x appears reasonable for the sector.
Deleveraging Progress: Long-term debt reduced from ₹6.51 crores to ₹2.21 crores, indicating improving balance sheet health.
No Promoter Pledging: Zero pledged shares eliminates one key governance risk factor.
Long-term Track Record: Five-year return of 637.04% demonstrates significant wealth creation for patient investors.

⚠️ Key Concerns

Weak Return Ratios: Average ROCE of 7.38% and ROE of 10.33% indicate suboptimal capital efficiency and profitability.
High Leverage: Debt-to-EBITDA ratio of 8.68x and EBIT-to-interest coverage of just 1.99x signal elevated financial risk.
Volatile Quarterly Performance: Revenue and profit swings between quarters suggest lumpy order execution and limited business visibility.
Annual Revenue Decline: FY25 sales of ₹51.00 crores down 17.70% from FY24, contradicting quarterly strength narrative.
Severe Underperformance: One-year return of -19.97% significantly lags both sector (-0.17%) and Sensex (-8.40%).
Zero Institutional Interest: Complete absence of FII and mutual fund holdings reflects quality concerns and limited liquidity.
Micro-cap Risks: Market cap of just ₹50.00 crores exposes investors to liquidity constraints and heightened volatility.

Outlook: What to Watch

Positive Catalysts

Order Book Visibility: Sustained revenue above ₹15-18 crores per quarter would signal genuine demand improvement beyond lumpy execution.
Margin Sustainability: Maintaining operating margins above 8.5% for consecutive quarters would validate operational improvements.
Further Deleveraging: Continued reduction in debt levels and improvement in interest coverage ratio would strengthen financial flexibility.
Institutional Entry: Any mutual fund or DII stake building would signal improving quality perception and provide valuation support.

Red Flags

Revenue Relapse: Return to sub-₹12 crore quarterly revenues would confirm Q4 was an aberration rather than sustainable trend.
Margin Compression: Operating margins falling below 7% would indicate pricing pressure or cost control challenges.
Working Capital Deterioration: Rising debtor days or inventory levels would strain cash flows and limit operational flexibility.
Promoter Stake Reduction: Any decline in promoter holding below 45% would raise concerns about confidence and alignment.

The Verdict: Cautious Hold for Existing Investors

HOLD

Score: 50/100

For Fresh Investors: Not recommended for fresh purchases. Whilst valuation appears attractive and Q4 results were encouraging, the company's weak return ratios, high leverage, and persistent quarterly volatility present substantial risks. The complete absence of institutional interest and severe one-year underperformance suggest structural concerns that cannot be dismissed based on a single strong quarter.

For Existing Holders: Continue to hold and monitor closely. The improving financial trend and attractive valuation provide some support, but set strict exit criteria. Consider reducing positions if quarterly revenues fall below ₹12 crores or if operating margins compress below 7% in upcoming quarters. The stock's long-term track record justifies patience, but only for investors with high risk tolerance.

Fair Value Estimate: ₹85-90 (15-22% upside potential based on sustainable earnings normalisation and margin improvement)

Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Investments in micro-cap stocks carry heightened risks including limited liquidity, volatility, and potential loss of capital.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Are Cranex Ltd latest results good or bad?
56 minutes ago
share
Share Via
When is the next results date for Cranex Ltd?
May 21 2026 11:18 PM IST
share
Share Via
Cranex Ltd is Rated Strong Sell
Apr 26 2026 10:10 AM IST
share
Share Via
Cranex Ltd is Rated Strong Sell
Apr 15 2026 10:10 AM IST
share
Share Via